Alzheimer's Disease Trial, Not Yet Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 50 years old or older
- You have been diagnosed with probable Alzheimer's disease based on recognised medical guidelines
- You scored between 10 and 24 on a standard memory and thinking test called the Mini-Mental State Examination at the screening and baseline appointments
- You scored 7 or below on a standard mood assessment for older adults called the Geriatric Depression Scale at screening
- You scored 4 or below on a test called the Hachinski Ischemic Scale, which helps tell apart different types of memory problems (confirm with trial site)
- Your brain MRI scan shows no damage in certain key brain areas, no more than 2 stroke-related spots larger than 1.5 cm, and a specific level of white matter changes on a rating scale called the Fazekas Scale (confirm with trial site)
- You have a caregiver who knows your condition well and, if possible, lives with you
- You are willing and able to sign a written consent form to take part
Who may not be able to join:
- You have another medical or neurological condition that could also be causing memory or thinking problems, separate from Alzheimer's disease
- You have a mental health diagnosis or symptoms such as hallucinations, severe depression, or delusions that could interfere with the study
- You have a serious, advanced, or unstable illness of any kind — such as heart, lung, digestive, or kidney problems — that could affect study results
- You have taken any medication for dementia within the two weeks before your baseline appointment
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Yongan Sun, Phd, Peking University First Hospital
Phone: 83572462
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Changes from baseline in Clinical Dementia Rating Sum of Boxes (CDR-SB)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.